glp-1 consultation maryland Glastonbury Weight Loss Injections What BMI Do You Need

Severe heart disease

These findings have led to NICE recommendations supporting the use of certain GLP-1 receptor agonists in patients with type 2 diabetes and established cardiovascular disease or at high cardiovascular risk

Book an appointment with us today to explore therapies that work for you

105 These results were supported by Srinivasan et al., 106 showing in their study an improvement in weight and insulin sensitivity, where using GLP-1RAs in monotherapy versus metformin achieved more than 5% weight loss

She is patient and nonjudgmental

Participants experienced a significant reduction in apnea events, with many achieving complete remission of symptoms